Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Perrins

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Chemistry & Biology|March 22, 2008
Synthetic mimetics of actin-binding macrolides: rational design of actin-targeted drugsRichard D Perrins, Giuseppe Cecere, Ian Paterson, et al.
Analytical Chemistry|October 28, 2011
Doing more with less: a method for low total mass, affinity measurement using variable-length nanotethersRichard D Perrins, Craig Orchard, Maria Zavodszky, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2020
A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinomaJohn Porter, Yao Ding, Sarah J M Hale, et al.
Bioconjugate Chemistry|December 25, 2018
DM1 Loaded Ultrasmall Gold Nanoparticles Display Significant Efficacy and Improved Tolerability in Murine Models of Hepatocellular CarcinomaSarah J M Hale, Richard D Perrins, Cristina Espinosa Garcı A, et al.
Nanomaterials (Basel, Switzerland)|November 26, 2022
Targeting Ultrasmall Gold Nanoparticles with cRGD Peptide Increases the Uptake and Efficacy of Cytotoxic PayloadRichard D Perrins, Lee-Anne McCarthy, Angela Robinson, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Chemistry & Biology|March 22, 2008
Synthetic mimetics of actin-binding macrolides: rational design of actin-targeted drugsRichard D Perrins, Giuseppe Cecere, Ian Paterson, et al.
Analytical Chemistry|October 28, 2011
Doing more with less: a method for low total mass, affinity measurement using variable-length nanotethersRichard D Perrins, Craig Orchard, Maria Zavodszky, et al.
Bioorganic & Medicinal Chemistry Letters|November 5, 2020
A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinomaJohn Porter, Yao Ding, Sarah J M Hale, et al.
Bioconjugate Chemistry|December 25, 2018
DM1 Loaded Ultrasmall Gold Nanoparticles Display Significant Efficacy and Improved Tolerability in Murine Models of Hepatocellular CarcinomaSarah J M Hale, Richard D Perrins, Cristina Espinosa Garcı A, et al.
Nanomaterials (Basel, Switzerland)|November 26, 2022
Targeting Ultrasmall Gold Nanoparticles with cRGD Peptide Increases the Uptake and Efficacy of Cytotoxic PayloadRichard D Perrins, Lee-Anne McCarthy, Angela Robinson, et al.
Pageof 1